Logo

US BioDefense to Launch Open Source Platform for Stem Cell R&D

Jan 21, 2005

NEW YORK, Jan. 21 (GenomeWeb News) - US BioDefense is developing an open source stem cell research platform designed to enable researchers to use bioinformatics tools in order to read, distribute, modify, and contribute to research.

 

"We intend to quickly scale up revenues by focusing on selling open source collaborative technology research and transfer tools as well as commercializing leading edge technology," said US BioDefense CEO David Chin. He added that this will help the company tap into  California's $3 billion Stem Cell Research Fund."

Breaking News
The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.